Outi Kristiina Savinen

Title: Innovations in Biosignal Measurement: The Contributions of Outi Kristiina Savinen

Introduction

Outi Kristiina Savinen, based in Helsinki, Finland, is a notable inventor recognized for her contributions to the field of biosignal measurement. With two patents to her name, she has made significant strides in developing innovative solutions that enhance our understanding and measurement of biological signals.

Latest Patents

Savinen's latest inventions include:

1. **Sensor for Measuring Biosignals**: This groundbreaking sensor features a unique design that includes a flexible non-conductive substrate, a conductive layer for signal transfer, a gel layer that aids in electrical signal conveyance, and a barrier layer that protects the conductive elements. The innovative arrangement of these components allows for effective biosignal measurement.

2. **Electrode for Obtaining a Biopotential Signal**: This advanced electrode is designed to acquire biopotential signals from the skin. It incorporates an adhesive element, an electrode body, an electrically conductive pad, a sponge soaked in conductive gel, and integrated skin abrasion means. This design ensures that signal acquisition is efficient while protecting the skin from any abrasive contact during measurement.

Career Highlights

Savinen is an integral part of General Electric Company, where her expertise and inventive spirit play a crucial role in advancing technology related to biosignal measurement. Her work is characterized by a dedication to improving the accuracy and functionality of measurement devices used in various health and research applications.

Collaborations

Throughout her career, Savinen has collaborated with esteemed colleagues, including Juha Virtanen and Magnus Kåll. These partnerships contribute to a rich exchange of ideas and foster innovation, amplifying the impact of their collective work in the scientific community.

Conclusion

Outi Kristiina Savinen stands out as a pioneering inventor in the realm of biosignal measurement. Her innovative patents not only reflect her technical prowess but also her commitment to advancing medical technology. As she continues her work at General Electric Company, her contributions will undoubtedly drive progress in the understanding and application of biosignals in healthcare and research.